Med Spa Treatments During Pregnancy and Breastfeeding: What's Safe

Each drug below carries a US label, and the labels themselves show the gap.

The Kybella label states that there are no adequate and well-controlled trials of the drug in pregnant women, and no information on whether it passes into breast milk.

The Botox Cosmetic label reports no adequate human data on use in pregnancy: animal studies showed reduced fetal weight at clinically relevant doses with maternal toxicity, and there are no data on whether the drug appears in breast milk.

The FDA's consumer page on dermal fillers says the same thing in one sentence: safety is unknown during pregnancy, while breastfeeding, and in patients under 22 years of age.

That is why nothing in this guide calls any injectable safe to use while pregnant or nursing.

Unknown is the word the sources themselves use, for toxins, fillers and Kybella alike.

The table below collects what each source — a drug label, the FDA, a professional society or a device maker — says for each treatment, so you can bring it to your obstetrician and the provider in one go.

The toxin in Botox is the clearest example of the pregnancy gap.

The Botox Cosmetic label states there are no studies or adequate data on the developmental risk of the drug in pregnant women, that animal studies showed reduced fetal weight at clinically relevant doses with maternal toxicity, and that there are no data on whether it passes into breast milk.

The FDA's page on dermal fillers answers the nursing question in the same breath: safety is unknown when the products are used during pregnancy and while breastfeeding, and in patients under 22.

If you are nursing and weighing lip filler, that sentence is the level of certainty the federal source offers.

Kybella, the injectable for fat under the chin, has the same label gap: no adequate and well-controlled trials in pregnant women, and no information on whether it passes into breast milk.

None of these statements describes a proven harm.

They describe an absence of data, which is a different thing — and the reason to put the decision in front of your obstetrician and the provider before booking anything elective.

For chemical peel treatments and for lasers in general, our research captured no FDA label or dermatology-society guidance that answers pregnancy or breastfeeding either way.

Where guidance does exist — for microneedling, skin tightening, tattoo removal and fat reduction — it comes from the FDA, professional societies and the makers, and it runs restrictive:

• FDA guidance on microneedling says the treatment may not be suitable for people who are pregnant or breastfeeding, alongside people taking isotretinoin now or in the past 6 months.
• VI, the maker of the VI Peel, lists pregnant or breastfeeding among the people its FAQ says should not get the peel.
• The American Academy of Dermatology says a skin-tightening procedure is not right for anyone who is pregnant.
• Device makers add their own screens: Ulthera's instructions for use say the device has not been evaluated in pregnant or breastfeeding women, Solta has not studied Thermage in pregnancy or breastfeeding, Sofwave lists pregnancy, breastfeeding or giving birth less than 3 months ago among its contraindications, and Cutera lists pregnancy as a Laser Genesis contraindication.
• For laser tattoo removal, the AAD says women who are pregnant or breastfeeding should not be treated.
• The American Society of Plastic Surgeons says patients who are pregnant or breastfeeding should not have nonsurgical fat reduction — cryolipolysis, injection lipolysis, radiofrequency or laser lipolysis.

Red light therapy is the open question.

We found no pregnancy-specific safety data in the sources we checked, and Cleveland Clinic's general summary — it appears safe short term when used as directed, misuse can damage skin or eyes, and the devices' long-term safety is not known — does not address pregnancy.

Ask your obstetrician before adding red light therapy sessions.

HydraFacial's US user guide for its Syndeo device is the document that counts here, not the marketing: it says the treatment is not for pregnant or lactating women because it has not been evaluated in them.

If a spa pitches you a hydrafacial package, ask what their own device manual says.

On ingredients, the American Academy of Dermatology's advice is direct: if you are pregnant or breastfeeding, check with your doctor before treating stretch marks, because some products contain ingredients such as retinol that can harm your baby.

One topical tretinoin label (Altreno) shows how those warnings read in full.

Observational studies have not established a risk of major birth defects, but absorption of the product may result in fetal exposure, there are reports of major birth defects similar to those seen with oral retinoids, and there are no data on breast milk.

Hydroquinone, a prescription lightening agent used for melasma, is no longer sold in non-prescription products in the US.

Our research did not capture a current US label's pregnancy guidance for it, so that question belongs to the dermatologist prescribing it and your obstetrician.

Stretch-mark creams sit in the same bucket.

Stretch marks are scars that form when skin stretches or shrinks quickly, and pregnancy is a classic trigger; a 2024 meta-analysis cited in our research puts the share of pregnant women who develop them at approximately 90%.

The AAD's warning comes from its stretch-mark guidance, so it covers these creams directly.

We will not print a list of safe ingredients, because our sources do not support one.

Ingredient questions go to your obstetrician and a dermatologist, product by product.

GLP-1 programs carry the clearest stop signals on any med spa menu.

The Wegovy label says to discontinue when pregnancy is recognized for weight reduction, and at least 2 months before a planned pregnancy because of semaglutide's long half-life.

The Zepbound label says the drug may cause fetal harm and should be stopped when pregnancy is recognized.

It also says Zepbound may reduce the effectiveness of oral birth control pills, so the label advises switching to a non-oral method or adding a barrier method for 4 weeks after starting and after each dose increase.

B12 shots and lipotropic injections sit at the edge of the weight-loss menu.

Vitamin B12 injections are prescription drugs; NIH describes them as typically used to treat B12 deficiency caused by pernicious anemia and other malabsorption conditions.

The cyanocobalamin label's indications are deficiency-related, and energy, weight loss and general wellness are not labeled uses.

Our research captured no FDA approval of lipotropic ('lipo') injections for weight loss — the B12 labels we read list no such indication.

None of our sources answers B12 injections in pregnancy specifically, so that question goes to your obstetrician with the exact product in hand.

Many med spa shots use methylcobalamin, which is not an FDA-approved injectable form — it sits on FDA's 503A Category 1 list (under evaluation) as of May 14, 2026 — while cyanocobalamin and hydroxocobalamin are approved drugs.

Melasma is so common in pregnancy that it is sometimes called the mask of pregnancy.

It often first appears during pregnancy or when starting birth control pills, and it may fade after delivery or stopping the pill.

That fade is part of the American Academy of Dermatology's reasoning: if you are pregnant, wait until you have your baby to treat melasma.

When treatment resumes later, the prescription options carry their own screens.

Oral tranexamic acid tablets are FDA-approved only for cyclic heavy menstrual bleeding, so their use for melasma is off-label.

The tablet label states it is not indicated for use in pregnant women and that it crosses the placenta.

The same label contraindicates it with combined hormonal contraceptives and in people with active or past blood clots or an intrinsic clotting risk.

Acne is the honest gap in our research: we captured no pregnancy-specific guidance for acne treatments.

Do not start, stop or continue a prescription acne product without your obstetrician and a dermatologist weighing in — the retinoid label warnings above show how those documents read.

Skin tags are the harmless extra some pregnancies add.

The AAD counts pregnancy among the factors that make people more likely to get them, and says they only need removal if they become irritated or bleed, affect eyesight on an eyelid, or become painful; otherwise removal is cosmetic.

In-office methods are cryosurgery (freezing), electrodesiccation and snip excision, and the AAD says removal is usually done in one visit.

What our sources do not answer is skin tag removal during pregnancy — ask your obstetrician first.

The FDA's warning applies at any time: no at-home mole or skin tag remover is approved, and FDA researchers documented 38 serious injuries from unapproved topical removers, including 14 facial injuries.

Melasma, and what dermatologists do about it after delivery, sits with the other skin and body concerns we cover.

No label or society in our research sets a general restart date after delivery.

Anyone quoting a universal number of weeks is speaking beyond these sources — though a device maker can set its own window, as Sofwave does.

What the sources do say: melasma may fade after delivery, which is part of why the AAD advises waiting until after the baby before treating it.

Device makers can add a postpartum window of their own.

Sofwave's contraindications include giving birth less than 3 months ago, alongside pregnancy and breastfeeding.

While you are nursing, the injectable picture does not improve.

The FDA says filler safety is unknown while breastfeeding, the Botox Cosmetic label has no data on whether the drug passes into breast milk, and Kybella's label has no breast-milk information either.

So resuming is a two-provider conversation — your obstetrician or midwife, and the licensed provider — covering what you had before, what you want now, and whether nursing changes the answer for each treatment.

No federal law defines what a 'med spa' is.

Whether one is regulated as a medical practice, and who may own it, is decided by each state's medical-practice, nursing and corporate-practice rules — AmSpa, the industry trade association, puts it plainly: med spas are medical practices.

That matters double when you are pregnant.

AmSpa's position is that injecting botulinum toxin is the practice of medicine because a prescription drug is being used, so it must be done by a physician, an independent-practice nurse practitioner or another licensed professional acting within their scope, under rules that vary by state.

Before you book anywhere, three screens: tell the practice you are pregnant or breastfeeding on the first call and ask how they handle it; ask who will perform or prescribe the treatment and what license they hold — nurse licenses (RN, APRN, LPN/VN) can be looked up through Nursys, the national database run by the National Council of State Boards of Nursing, whose data comes from participating boards of nursing, so non-participating boards must be checked directly; and ask whether the provider coordinates with your obstetrician.

The full vetting checklist — the medical director, who will treat you, provider training, genuine product and a real consultation — is in our guide to how to choose a med spa.